Betoptic is indicated for the reduction of elevated intraocular pressure in patients with ocular hypertension and chronic open angle glaucoma.
BETOPTIC SUSPENSION SINGLE DOSE lowers the intraocular pressure and is indicated in patients with chronic open-angle glaucoma and ocular hypertension.
BETOPTIC SUSPENSION lowers the intraocular pressure and is indicated in patients with chronic open-angle glaucoma and ocular hypertension.
The FDA will convene an in-person meeting of the Peripheral and Central Nervous System Drugs Advisory Committee (PCNS) on Monday, June 10, 2024, to discuss donanemab, which Eli Lilly and Company has submitted for the treatment of early symptomatic Alzheimer’s disease. The open public hearing portion of the meeting will be conducted virtually
Parkinson's disease: the struggle to control symptoms After Alzheimer's, Parkinson's disease (PD) is the most common neurodegenerative disorder, affecting more...
This guideline covers managing Crohn’s disease in children, young people and adults.
Medtronic and Covidien have announced the receipt of U.S. Federal Trade Commission (FTC) clearance of Medtronic's proposed acquisition of Covidien....
Parkinson's Awareness Week begins Monday 9th April and surrounds Parkinson's Awareness Day, which takes place this year on Wednesday 11th April.